Nature and Basis Statements of
Conflict(s) of Interest for Voting Members of FDA Advisory Committee
The Agency is revising its procedures regarding
the disclosure of conflicts of interest and waivers for voting
advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided
as an interim measure to comply with the requirements of this
Meeting of the Peripheral and Central Nervous System Drugs
March 7, 2006 Meeting
Steven DeKosky, M.D.
Larry Goldstein, M.D.
Lily Jung, M.D., M.M.M.
Karl Kieburtz, M.D.
Ralph Sacco, M.D.
Page updated: February 17, 2006